Methods: In this single-group, longitudinal study, participants underwent baseline pre-testing (T0) and post-testing at 3 (T1), 6 (T2), and 12 (T3) months after a 4-week group ICM program.
Results: K- pre-DM was significantly increased (T1 vs. T0, p=.01; T2 vs. T0, p=.00; T3 vs. T0, p=.01) throughout the 12-month period. Compared with T0, dietary behavior was significantly better at T1 (p=.01), and health-promoting lifestyle was significantly improved at T2 (p=.02) and T3 (p=.01). BW and BMI were significantly lower at T1 (p<.00, p=.00) and T2 (p<.00, p=.00) than at T0. Fasting blood sugar was significantly lower than baseline at T2 (p=.02) and T3 (p=.02). The HbA1C level was significantly lower at T1 (p<.00), T2 (p<.00) and T3 (p<.00) than at T0. The HDL level was significantly higher at T2 (p<.00) than at T0. During the 12-month study period, physical activity was maintained at moderate intensity. In addition, Tchol, LDL, and TG were sustainably decreased throughout the study period.
Conclusion: The results of this study suggest that the ICM intervention is effective and may potentially prevent pre-DM progression.
Practice implications: This study provides evidence-based data to support the potential effects of a theory-driven protocol in preventing disease progression in people with pre-diabetes. Health care providers may apply it to people at high risk of developing diabetes in clinical and community care.